Outcome | Objective |
---|---|
Effectiveness | #1: To determine whether a bCBT treatment group as provided by VA PC-MHI clinicians is superior to a usual-care control group at post treatment and 8- and 12-month follow-ups, as measured by: |
a) depression and anxiety scores (Patient Health Questionnaire-9 and Beck Anxiety Inventory) | |
b) cardiopulmonary disease outcomes (Chronic Respiratory Questionnaire and Kansas City Cardiomyopathy Questionnaire). | |
Implementation | #2: To assess bCBT adoption and fidelity, as measured by: |
a) bCBT patient engagement (one or more sessions) and adherence (four or more sessions) | |
b) PC-MHI clinician bCBT adherence and competency ratings as evaluated by expert audio session reviews. |